Insmed Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -761.93 M

Insmed Incorporated Operating Cash Flow is USD -761.93 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 32.75% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Insmed Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -573.98 M, a 29.98% change year over year.
  • Insmed Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -441.58 M, a 29.81% change year over year.
  • Insmed Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -340.18 M, a 17.43% change year over year.
  • Insmed Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -289.69 M, a 23.41% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities